223 results
Keyword Diane Remove keyword
-
List item
Orphan designation: 1,2:5,6-Dianhydrogalactitol for: Treatment of glioma
Date of designation: 24/01/2013, Positive, Last updated: 28/04/20211,2:5,6-Dianhydrogalactitol Overview On 24 January 2013 … United Kingdom, for 1,2:5,6-dianhydrogalactitol for the treatment of glioma … information to show that 1,2:5,6-dianhydrogalactitol might be of significant benefit … -
List item
Referral: Glucophage/Glucophage Forte/Risidon/Dianben
metformin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/10/2000, EC decision date: 06/02/2001, Last updated: 07/02/2001age/Glucophage Forte/Risidon/Dianben … Glucophage/Glucophage Forte/Risidon/Dianben (metformin) contains the … Glucophage/Glucophage Forte/Risidon/Dianben International Non-Proprietary … -
List item
National expert: Diana Hartenstein, Paul Ehrlich Institute (updated)
- Declaration of interests - 79.8 KB | PDF
- Curriculum Vitae - 16.6 KB | PDF
Diana Hartenstein … Diana Hartenstein … Vitae PERSONAL INFORMATION Diana Hartenstein WORK EXPERIENCE August … -
List item
National expert: Diana Fülöpová, Institute for State Control of Veterinary Biologicals and Medicaments (updated)
- Declaration of interests - 79.84 KB | PDF
- Curriculum Vitae - 17.42 KB | PDF
Diana Fülöpová … Diana Fülöpová … Vitae PERSONAL INFORMATION Diana Fulopova WORK EXPERIENCE September … -
List item
National expert: DIANA TOTEDA, Italian Medicines Agency (updated)
- Declaration of interests - 79.78 KB | PDF
- Curriculum Vitae - 17.86 KB | PDF
DIANA TOTEDA … DIANA TOTEDA … Vitae PERSONAL INFORMATION DIANA TOTEDA WORK EXPERIENCE February … -
List item
National expert: Diana Leleckaite, Lithuania States Medicines Control Agency (updated)
- Declaration of interests - 79.81 KB | PDF
- Curriculum Vitae - 18.14 KB | PDF
Diana Leleckaite … Diana Leleckaite … Vitae PERSONAL INFORMATION Diana Leleckaite WORK EXPERIENCE July … -
List item
National expert: Diane Farrugia, Medicines Authority (updated)
- Declaration of interests - 80.33 KB | PDF
- Curriculum Vitae - 18.89 KB | PDF
Diane Farrugia … Diane Farrugia … Vitae PERSONAL INFORMATION Diane Farrugia WORK EXPERIENCE May … -
List item
National expert: Diana Laura Bassula, Institute for Control of Biological Products & Veterinary Drugs (updated)
- Declaration of interests - 79.83 KB | PDF
- Curriculum Vitae - 16.75 KB | PDF
Diana Laura Bassula … Diana Laura Bassula … Vitae PERSONAL INFORMATION Diana Laura Bassula WORK EXPERIENCE October … -
List item
National expert: Diana Gonzalez Bermejo, Spanish Agency of Medicines and Medical Devices (updated)
- Declaration of interests - 79.92 KB | PDF
- Curriculum Vitae - 16.92 KB | PDF
Diana Gonzalez Bermejo … Diana Gonzalez Bermejo … Vitae PERSONAL INFORMATION Diana Gonzalez Bermejo WORK EXPERIENCE … -
List item
National expert: Melanie Diane Klok, Medicines Evaluation Board (updated)
- Declaration of interests - 80.63 KB | PDF
- Curriculum Vitae - 18.13 KB | PDF
Melanie Diane Klok … Melanie Diane Klok … Vitae PERSONAL INFORMATION Melanie Diane Klok WORK EXPERIENCE September … -
List item
National expert: Diana van Riet-Nales, Medicines Evaluation Board (updated)
- Declaration of interests - 80.22 KB | PDF
- Curriculum Vitae - 20.12 KB | PDF
Diana van Riet-Nales … Diana van Riet-Nales … Vitae PERSONAL INFORMATION Diana van Riet-Nales WORK EXPERIENCE September … -
List item
Press release: Benefits of Diane 35 and generics outweigh risks in specific patient group
PRAC, Last updated: 17/05/2013Benefits of Diane 35 and generics outweigh … concluded that the benefits of Diane 35 (cyproterone acetate 2 … reproductive age. Furthermore, Diane 35 should only be used for … -
List item
Press release: European Medicines Agency update on Diane 35 and generics used in the treatment of acne
Last updated: 30/01/2013Medicines Agency update on Diane 35 and generics used in the … marketing authorisation for Diane 35 (cyproterone acetate 2 … data. ANSM considered that Diane 35 and its generics carry … -
List item
Press release: European Medicines Agency starts safety review of Diane 35 and its generics
PRAC, Last updated: 08/02/2013Agency starts safety review of Diane 35 and its generics … started a safety review of Diane 35 (cyproterone acetate 2 … marketing authorisations for Diane 35 and its generics for acne … -
List item
News: European Medicines Agency reiterates PRAC recommendation for Diane 35 and generics
PRAC, Last updated: 17/05/2013reiterates PRAC recommendation for Diane 35 and generics … PRAC) that the benefits of Diane 35 and its generics outweigh … risk of thromboembolism, Diane 35 and its generics can be … -
List item
News: Pharmacovigilance Risk Assessment Committee (PRAC) invites stakeholders' feedback in review of Diane 35 and its generics
PRAC, Last updated: 12/02/2013stakeholders' feedback in review of Diane 35 and its generics … part of the safety review of Diane 35 and other medicines containing … started a safety review of Diane 35 (cyproterone acetate 2 … -
List item
Press release: Benefits of Diane 35 and its generics outweigh risks in certain patient groups - PRAC recommendation endorsed by CMDh
CMDh, Last updated: 30/05/2013Benefits of Diane 35 and its generics outweigh … Benefits of Diane 35 and its generics outweigh … EMA/318380/2013 Benefits of Diane 35 and its generics outweigh … -
List item
Referral: Cyproterone- and ethinylestradiol-containing medicines
cyproterone, ethinyl estradiol, associated names: Acnemine, Acneson, Chloe, Clairette, Cyprest, Cyprodiol, Diane 35, Dianette, Feminil, Minerva, Zyrona, Article 107i procedures
Status: European Commission final decision, opinion/position date: 29/05/2013, EC decision date: 25/07/2013, Last updated: 05/08/2013Benefits of Diane 35 and its generics outweigh … EMA/318380/2013 Benefits of Diane 35 and its generics outweigh … concluded that the benefits of Diane 35 (cyproterone acetate … -
List item
Referral: Baxter dialysis solutions
Article 31 referrals
Status: European Commission final decision, opinion/position date: 20/10/2011, EC decision date: 16/12/2011, Last updated: 20/11/2013Castlebar plant. These include: Dianeal, Extraneal and Nutrineal solutions … endotoxins in batches of Dianeal, Extraneal and Nutrineal made … Castlebar plant. These include: Dianeal, Extraneal and Nutrineal solutions … -
List item
Press release: European Medicines Agency recommends action plan to deal with possible presence of endotoxins in Baxter peritoneal dialysis solutions
CHMP, Last updated: 17/12/2010peritoneal dialysis solutions Dianeal, Extraneal and Nutrineal … basis all side effects with Dianeal, Extraneal and Nutrineal that … through which the batches of Dianeal, Extraneal and Nutrineal that … -
List item
Combined hormonal contraceptives
Last updated: 22/11/2013Diane 35 and generics …
-
List item
Veterinary focus group meeting with stakeholders: revision of the reflection paper on anthelmintic resistance
European Medicines Agency, London, UK, 13/06/2016, Last updated: 10/02/2017diane.vilquin@ema.europa.eu … -
List item
Press release: Review of the manufacture of Baxter's peritoneal dialysis solutions initiated over potential presence of endotoxins in some batches
CHMP, Last updated: 21/01/2011certain Baxter PD solutions (Dianeal, Extraneal and Nutrineal … considers that alternative Dianeal, Extraneal and Nutrineal solutions … certain Baxter PD solutions (Dianeal, Extraneal and Nutrineal … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 February 2013
PRAC, Last updated: 08/02/2013Agency starts safety review of Diane 35 and its generics Evra … Agency starts safety review of Diane 35 and its generics (08/02/2013 … -
List item
Quality assessors training
London, from 27/10/2009 to 28/10/2009, Last updated: 27/10/2009Quality assessors training - Diana van Riet PDF icon application/pdf … Introduction to quality assessment - Diana van Riet PDF icon application/pdf … Quality: Basics – Chair: Diana van Riet Session Speaker …